Fibrate treatment can increase serum creatinine levels
dc.contributor.author | Tsimihodimos, V. | en |
dc.contributor.author | Kakafika, A. | en |
dc.contributor.author | Elisaf, M. S. | en |
dc.date.accessioned | 2015-11-24T19:15:52Z | |
dc.date.available | 2015-11-24T19:15:52Z | |
dc.identifier.issn | 0931-0509 | - |
dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/21575 | |
dc.rights | Default Licence | - |
dc.subject | Clofibric Acid/*adverse effects/analogs & derivatives | en |
dc.subject | Creatinine/*blood | en |
dc.subject | Fenofibrate/*adverse effects | en |
dc.subject | Fibric Acids | en |
dc.subject | Gemfibrozil/*adverse effects | en |
dc.subject | Humans | en |
dc.subject | Hypolipidemic Agents/*adverse effects | en |
dc.subject | Kidney Diseases/complications/physiopathology | en |
dc.subject | Urea/blood | en |
dc.title | Fibrate treatment can increase serum creatinine levels | en |
heal.access | campus | - |
heal.fullTextAvailability | TRUE | - |
heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/11390746 | - |
heal.identifier.secondary | http://ndt.oxfordjournals.org/content/16/6/1301.1.full.pdf | - |
heal.journalName | Nephrol Dial Transplant | en |
heal.journalType | peer-reviewed | - |
heal.language | en | - |
heal.publicationDate | 2001 | - |
heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
heal.type | journalArticle | - |
heal.type.el | Άρθρο Περιοδικού | el |
heal.type.en | Journal article | en |
Αρχεία
Φάκελος/Πακέτο αδειών
1 - 1 of 1
Φόρτωση...
- Ονομα:
- license.txt
- Μέγεθος:
- 1.74 KB
- Μορφότυπο:
- Item-specific license agreed upon to submission
- Περιγραφή: